Literature DB >> 3937552

Structural studies on acid unfolding and refolding of recombinant human interferon gamma.

Y R Hsu, T Arakawa.   

Abstract

Interferon gamma is distinguished from other types of interferons in its instability upon acid treatment, as demonstrated by a loss of antiviral activity. Acid unfolding and refolding experiments were performed with recombinant DNA derived human interferon gamma. When the protein was subjected to unfolding and refolding, the refolded protein showed two peaks (peaks I and II) in gel filtration which have been shown to differ in size, structure, and antiviral activity. When the smaller, peak II, form was unfolded by dialysis against 0.01 M HCl containing 0.1 M NaCl (pH 2) and refolded by dialysis against various solvents at neutral pH, it re-formed as peak II but also generated peak I, and the ratio of the two forms was dependent on protein concentration and solvent conditions. Higher protein concentrations and higher ionic strength led to a greater ratio of peak I to peak II. Phosphate buffers caused precipitation of peak I. Since peak II is 4-8 times more active than peak I in the antiviral bioassay, generation of peak I by acid treatment of peak II should lead to a decrease in antiviral activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3937552     DOI: 10.1021/bi00348a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Production and characterization of human gamma interferon from Escherichia coli.

Authors:  L Perez; J Vega; C Chuay; A Menendez; R Ubieta; M Montero; G Padron; A Silva; C Santizo; V Besada
Journal:  Appl Microbiol Biotechnol       Date:  1990-07       Impact factor: 4.813

Review 2.  Stability of protein pharmaceuticals.

Authors:  M C Manning; K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

3.  The effect of benzyl alcohol on recombinant human interferon-gamma.

Authors:  X M Lam; T W Patapoff; T H Nguyen
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

4.  Use of synthetic peptides to identify an N-terminal epitope on mouse gamma interferon that may be involved in function.

Authors:  H I Magazine; J M Carter; J K Russell; B A Torres; B M Dunn; H M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

Review 5.  The purification of eukaryotic polypeptides synthesized in Escherichia coli.

Authors:  F A Marston
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

6.  Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.

Authors:  J L Cleland; A J Jones
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

7.  Structural features of interferon-gamma aggregation revealed by hydrogen exchange.

Authors:  Scott A Tobler; Erik J Fernandez
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.